Healthcare Press Releases - EmailWire Press Release Distribution Services

(EMAILWIRE.COM, July 23, 2018 ) ReseachReports.com has recently announced the addition of a new research report to its intensifying repository. The research report, titled Ferrite Chip Beads Market, offers a clear understanding of the subject matter. The report has been hoarded using primary and secondary research methodologies. Both these methods are intended towards collaborating accurate and exact data relating the market dynamics, historical events, and the current market scenario. Moreover, the report also includes a SWOT analysis that determines the strengths, weaknesses, opportunities, and threats impacting the segments of the overall market.

Get sample copy of this report at: https://www.researchnreports.com/request_sample.php?id=63450

Key Players: LairdTech,Allied Components,Murata,Abracon,API Delevan,Kemet,Vishay,TDK,TE Connectivity

The high event of psychological wellness issues, for example, discouragement, stress, nervousness, and fixation among the general population are filling the development of the worldwide Ferrite Chip Beads advertise. Various wellbeing professionals are picking up proficiency with this software as it outlines the most ideal treatment for the patients experiencing mental clutters.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

These frameworks likewise assist the clients with booking arrangements, oversee plans, and facilitate bills and installments through cell phones. The examination report endeavors to comprehend the creative methodologies taken by merchants in the worldwide market to offer item differentiation through a Doorman's five powers investigation. It likewise calls attention to the manners by which these organizations can brace their remain in the market and upsurge their incomes amid the conjecture time frame.

Get discount at: https://www.researchnreports.com/ask_for_discount.php?id=63450

The worldwide Ferrite Chip Beads showcase is additionally being driven by the expanding maturing population, developing consumption on social insurance, rising number of government initiatives to digitalize human services, and increasing selection of wearable gadgets. Continuous mechanical headways and the relentless penetration of web in the remote corners of the world are additionally in charge of the outstanding development of the worldwide Ferrite Chip Beads advertise.
Get discount at: The research report segments the global Ferrite Chip Beads market on the basis of application into clinics, residential, and hospitals, and others. On the basis of geography, the global market is divided into North America, China, Europe, Japan, India, and Southeast Asia. The research report observes that North America will be a key regional market in the overall Ferrite Chip Beads market.

Mr. Sunny Denis
+1-8886316977
sales@researchnreports.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 21, 2018 ) Health Information Exchange (HIE) permits healthcare professionals and patients to access and share patient's medical information electronically. The purpose of HIE is to help in accessing and retrieving clinical data in order to provide efficient, safe, effective, timely, and patient centric care. HIE helps in collaborating healthcare stakeholders such as doctors, pharmacists, nurses, and various healthcare providers by reducing tedious administrative tasks and provides transparency in the healthcare industry. In recent years, HIE has become an essential part of the health information technology infrastructure since it provides ease in transfer of essential patient data and records.

Download PDF Brochure @ http://bit.ly/2NbXjbE

Rising awareness of the need to access health information of patients and the establishment of various nonprofit organizations promoting the use of HIE for patient data management are expected to be the driving factors in the market in the coming years. The rise in the need for data exchange between hospitals and other patient care centers is expected to provide growth opportunity in the market during the forecast period.

The "Global Health Information Exchange Market Analysis to 2025" is a specialized and in-depth study of the health information exchange industry with a focus on the global market trend. The report aims to provide an overview of global health information exchange market with detailed market segmentation by set up, type, implementation model, solution, application, and end user. The global health information exchange market is expected to witness substantial growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

Based on set up, the market is segmented as, public and private. The market is categorized based on type such as, query based, direct and consumer mediated. On the basis of implementation model, the HIE market is categorized as centralized, decentralized and hybrid model. The market is further segmented based on the solution as, portal centric, messaging centric and platform centric. By application, the HIE market is classified as workflow management, internal interfacing, web portal development, and other applications. On the basis of end users, the HIE market is segmented as pharmacies, healthcare providers and healthcare payers.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global health information exchange market based on set up, type, implementation model, solution, application, and end user. It also provides market size and forecast till 2025 for overall health information exchange market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South and Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

The market of Health Information Exchange is anticipated to witness rapid growth in the region of North America in the coming years, due to rising awareness regarding data collection and transfer between healthcare payers and providers. Also, the rise in the number of nonprofit organizations in the United States during the previous years has been a driving factor in the region. The market of HIE is anticipated to witness growth at a substantial rate during the forecast period, owing to the rise in the patient population in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Inquire before Buying @ http://bit.ly/2NOwnQa

The report also includes the profiles of key health information exchange manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past three years.

Some of the key players influencing the market are Allscripts, Orion Health, Medicity, General Electric Company, NextGen Healthcare Information Systems, LLC, Oracle, eClinicalWorks, and Optum, Inc. among others.

Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 21, 2018 ) Radio-Frequency Identification (RFID) uses radio waves to read and capture information stored on a tag attached to an object. The tag can be read from several feet distance and it does not need to be in direct line-of-sight of the reader. RFID technology is used in patient safety, supply chain applications, and in quality assurance applications. The technology can be deployed in hospitals and clinics to improve patient flow, reduce medial errors, improve asset utilization rates, and manage inventories & implants, among others.

Download PDF Brochure @ http://bit.ly/2Naobsp

Improvement of inventory management in hospitals, pharmacies, & biotechnology companies, low-cost and high efficiency of the RFID systems, patient safety by healthcare providers, and adoption of automated process in hospitals & pharmacies is expected to drive the growth of the market. Moreover, government policies to refine tracking system for medical devices and biological products is expected to provide opportunity for the growth of RFID in Healthcare market during the forecast period.

The "Global RFID in Healthcare Market Analysis to 2025" is a specialized and in-depth study of the RFID in Healthcare industry with a focus on the global market trend. The report aims to provide an overview of global RFID in healthcare market with detailed market segmentation by product, application, end user, and geography. The global RFID in Healthcare market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The RFID in healthcare market is segmented based on product as, tags, readers, printers, and software. On the basis of application the RFID in Healthcare market is segmented into monitoring and tracking. Based on the end user, the market is segmented as hospitals, and pharmaceutical & biotechnology companies.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global RFID in Healthcare market based on product, application and end user. It also provides market size and forecast till 2025 for overall RFID in healthcare market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is anticipated to hold largest share of the RFID in healthcare market, followed by Europe. Factors such as increasing number of collaboration in the medical device industry and presence of sophisticated healthcare infrastructure are driving the growth of the market in this region. Moreover, need for tracking medical devices in the developing countries such as China and India and low cost of RFID component provided by China are anticipated to provide opportunities in RFID in healthcare market in Asia.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Inquire before Buying @ http://bit.ly/2Lfr8r8

The report also includes the profiles of key RFID in healthcare companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Some of the key players influencing the market 3M, Hitachi, Ltd., NewAge Industries, Inc., AAID Security Solutions, Inc., Motorola Mobility LLC, IBM, Siemens AG, ACC Systems Incorporated, BearingPoint, and AMERICAN RFID SOLUTIONS, LLC.

Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 21, 2018 ) An exclusive X-ray Security Scanner Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global X-ray Security Scanner Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global X-ray Security Scanner market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Download Sample PDF at http://bit.ly/2zXwFS3

Leading X-ray Security Scanner Market Players:

1. Astrophysics, Inc.
2. ADANI
3. Eurologix Security Group
4. L3 Security & Detection Systems
5. NUCTECH COMPANY LIMITED
6. OSI Systems, Inc.
7. Gilardoni S.p.A.
8. Kromek Group plc
9. Smiths Detection Inc.
10. TELEDYNE ICM
Worldwide X-ray Security Scanner Market Analysis to 2025 is a specialized and in-depth study of the X-ray Security Scanner industry with a focus on the global market trend. The report aims to provide an overview of global X-ray Security Scanner market with detailed market segmentation by product/application and geography. The global X-ray Security Scanner market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the X-ray Security Scanner players and offers key trends and opportunities in the market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global X-ray Security Scanner market based on product and application. It also provides market size and forecast till 2025 for overall X-ray Security Scanner market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Inquire About this Report at http://bit.ly/2O5wYgx

Also, key X-ray Security Scanner market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Reason to Buy

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global X-ray Security Scanner market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the X-ray Security Scanner market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Get Complete Report With TOC and Company Profiles at http://bit.ly/2JKya5E

Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 22, 2018 ) Blood purification equipment work similar to the dialysis equipment. These equipment use thin fibers to capture and remove viruses and filters the blood. The equipment requires the drawing of blood through an artery, which is sent through a tube into the equipment, then back into the body.

Blood purification equipment market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing cases of acute kidney failure, prevalence and growing geriatric population. Various technological developments in the healthcare industry across geography and growing cardiological disorders cases are expected to offer growth opportunities for the players operating in the market.

Download PDF Brochure @ http://bit.ly/2mua85F

The Global Blood Purification Equipment Market Analysis to 2025 is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global blood purification equipment market with detailed market segmentation by product, end user and geography. The global blood purification equipment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global blood purification equipment market is segmented on the basis of product, end user, and geography. The product segment includes, immunosorbent device, hemoperfusion device, plasma exchange device, hemodialysis device, blood filtration device. Based on end user, the market is segmented as, medical centre, hospitals, and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Blood Purification Equipment Market based on product, end user, and geography. It also provides market size and forecast till 2025 for overall Blood Purification Equipment Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the blood purification equipment market in the coming years, owing to factors such as, improved healthcare infrastructure and rising number of cardiovascular disorders in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Inquire before Buying @ http://bit.ly/2LzeKlY

The report also includes the profiles of key Blood Purification Equipment Market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Some of the key players influencing the market are CytoSorb, NxStage Medical, Inc., Spectral Medical Inc., Filtertek, Inc., Nikkiso America, Inc., Gmeditech, Jafron Biomedical Co., Medtronic, and General Electric Company.

Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) Global Childhood Vaccines Market
Vaccines are the biological preparations which provide the active acquired immunity to the particular disease. Generally, the vaccines contain a substance that resembles the disease causing agent, and is prepared from killed or weakened form of microbe, its toxin or its surface proteins. Agents present in the vaccines stimulate the immune system of the body for recognition of the agent as foreign so that the bodys immune system can easily recognize and destroy any of these microorganisms that it later encounters. Childhood vaccines are commonly administered to the age group of 3-8 years which may include DPT vaccine for Diphtheria, Pertussis, and Tetanus, Hepatitis, Influenza, and Measles vaccines, among others.

The global Childhood Vaccines Market is expanding at robust CAGR due to increase in the birth rate. Increase in the awareness regarding vaccination of various diseases in developed countries, initiations took by various government and non-governmental organizations such as World Health Organization (WHO), and Centre for Disease Control and Prevention (CDC), and growth in adoption of vaccines fuel the childhood vaccines market growth over the forecast period. Furthermore, government insurance and reimbursement scenario, low cost of vaccines, development of new vaccines for various diseases, and an increase in the healthcare expenditure might boost the global childhood vaccines market growth over the forecast period. However, adverse effects associated with the vaccines, stringent regulatory policies, and lack of awareness regarding the diseases and vaccination in low-income countries might hamper the growth of childhood vaccines market over the forecast period.

Get Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-PBI-HnM-3168

The childhood vaccines market is segmented on the basis of vaccine type, route of administration applications, and end-user

Based on vaccine type, the childhood vaccines market has been segmented into the following:
Inactivated Vaccines
Attenuated Vaccines
Toxoid Vaccines
Subunit Vaccines
Conjugate Vaccines
Others

Based on the route of administration, the childhood vaccines market has been segmented into the following:
Oral
Intramuscular
Intradermal
Subcutaneous
Intranasal

Based on the application, the childhood vaccines market has been segmented into the following:
Diphtheria
Pertussis
Tetanus
Polio
Measles
Hepatitis-B
Others

Based on the composition, the childhood vaccines market has been segmented into the following:
Mono vaccines
Combination vaccines

Based on the end-user, the childhood vaccines market has been segmented into the following:
Hospitals
Clinics
Vaccination Centres

Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-PBI-HnM-3168

Nowadays, the global childhood vaccines market is in the mature stage, competitors are focusing on the development of new vaccines for various diseases. Increase in the prevalence of various diseases such as measles, hepatitis, diphtheria, and among others might fuel the growth of childhood vaccines market. Acquisitions & mergers, collaborations, launch of new products, and technological developments are some of the key strategies followed by various companies for increasing their share in the global childhood vaccines market over the forecast period. For instance, in January 2011, Sanofi Pasteur has inked a licensing deal with Germanys Organobalance that gives Sanofi access to a modified yeast strain for use in vaccines. Similarly, in October 2014, MabVax Therapeutics Holdings, Inc., announced that the FDA has granted an orphan drug designation to the Companys vaccine intended for the treatment of the childhood cancer neuroblastoma. In addition, in January 2013 GSK, Biological E partner on childhood vaccine to produce a 6-in-1 vaccine to protect against polio and 5 other diseases. The innovation of single vaccine for multiple diseases might fuel the global childhood vaccines market growth over the forecast period.

Geographically, the childhood vaccines market has been segmented into the following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. U.S. childhood vaccines market is expected to dominate the North America regional revenue share over the coming years due to burgeoning awareness levels and adoption of state-of-art technologies to the production of vaccines. North America holds the largest share attributed to increase in the prevalence of various diseases such as pertussis (In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S), measles, and hepatitis etc. In addition, increase in the R&D of vaccines, rise in the healthcare expenditure, and favourable reimbursement scenario might fuel the childhood vaccines market growth in the North America region. Europe childhood vaccines market holds a dominant share owing to increase in the awareness of vaccination regarding various diseases. For instance, France made that vaccination is mandatory from 2018 because of children are dying of measles (according to the European Centre for Disease Prevention and Control, there were 79 cases of measles reported in France in the first two months of 2018). Increase in the healthcare expenditure and research and development activities boost the market in the Europe. Asia-Pacific is an emergent market for childhood vaccines due to increase in the birth rate, especially in India and China. Increase in adoption for vaccination, and growth in the prevalence of infectious disease might fuel the childhood vaccines market growth in Asia-Pacific over the forecast period. Due to less cost of vaccines, Latin America and the Middle East and Africa also hold a significant share in childhood vaccination market.

Some of the players in childhood vaccines market are MedImmune (U.S.), Johnson & Johnson Services Inc., (U.S.), Merck & Co., Inc. (U.S.), Sanofi (France), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (U.S.), Astellas Pharma (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline plc, (U.K.), Protein Sciences Corporation (U.S.), Novartis AG (Switzerland), Organobalance GMBH (Germany), Biological E (India), and Mabvax Therapeutics Holdings Inc. (U.S.) to name a few.

Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-PBI-HnM-3168/

In June 2018, Takeda and BE collaborate to develop low-cost vaccines for low and middle-income countrie

In April 2018, Serum Institute of India Pvt. Ltd., acquired Nanotherapeutics for the development of polio vaccine

In January 2018, FDA approved Sanofi Pasteurs active immunization against tetanus, diphtheria, poliomyelitis, and pertussis in children 4 to 6 years of age

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) Global Elastomeric Infusion Pumps Market Report Description:
Global elastomeric infusion pumps market report gives comprehensive outlook on elastomeric infusion pumps across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on elastomeric infusion pumps market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user, and geographic regions. This report studies elastomeric infusion pumps market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, elastomeric infusion pumps market report includes technology advancements; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed elastomeric infusion pumps market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the elastomeric infusion pumps market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and usage of elastomeric infusion pumps.

Global Elastomeric Infusion Pumps Market:
Global elastomeric infusion pumps market estimated to be valued US$ 425 Mn in 2018 and poised to grow at CAGR of 6.0% over 2018-2024. Market for elastomeric infusion pumps projected to reach US$ 602 Mn by 2024 owing to increasing adoption of elastomeric infusion pumps in cancer therapy and pain management.

Get Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-PBI-HnM-3156

Market for elastomeric infusion pumps driven by rising demand across the healthcare setups
The market for elastomeric infusion pumps is driven increasing adoption of these pumps in different healthcare setups such as hospitals, clinics, homecare, and ambulatory surgical centers across the globe. The homecare market for elastomeric infusion pumps is driven by rise in usage of disposable pumps and hospital market is expected to drive the market growth significantly owing to increasing hospitalizations due to several chronic diseases which is expected to drive the pain management segment over the forecast period. Moreover, increase in adoption, growing demand for small disposable infusion pumps, and its wide range of application in various fluid drug delivery systems expected to drive the market revenue growth over the forecast period.
Technological advances expected to drive market growth positively

The technological advances in elastomeric infusion pump system offers several advantages over electronic pumps including portability, feasible demonstration, low weight, size, ease of use, and less interference with sleep, which is expected to create market demand for elastomeric infusion pumps across the globe. However, product recalls in the recent times owing to design issues expected to prompt the product manufacturers to invest in product development to address the design defects in the products, which in turn expected to drive market revenue growth positively over the forecast period
North America market leads the global elastomeric infusion pumps market

North America market leads the global elastomeric infusion pumps market and projected to remain same over the forecast period owing to reimbursement policies in the region. Europe and Asia-pacific elastomeric infusion pumps market projected to grow at significant CAGR over the forecast period in comparison with other regions

Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-PBI-HnM-3156

Competition Assessment
Key players profiles in the global elastomeric infusion pumps market include:
Ambu A/S (Denmark)
Baxter International Inc. (U.S.)
Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Halyard Health, Inc. (U.S.)
Leventon S.A.U (Spain)
Nipro Corporation (Japan)

Players in the elastomeric infusion pumps market are focusing on expanding product portfolio and increasing market penetration through Continuous Medical Education (CME) programs to garner larger market share.

Key Findings of the Report:
Global elastomeric infusion pumps market expanding at 6.0% CAGR over 2018 to 2024 to reach market value of US$ 602 Mn by 2024
Based on product type, continuous rate elastomeric pumps accounted for larger market revenue share in 2017 owing wider application in different treatments
Hospitals are the prime buyers for the elastomeric infusion pumps across the globe and expected to remain attractive over the forecast period
Players focusing on launching products expand market presence in global elastomeric infusion pumps market.

Key Features of the Report:
The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startups details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Enquiry for Customization@ www.qurateresearch.com/report/customize/HnM/QBI-PBI-HnM-3156

Detailed Segmentation
By Product Type
o Continuous Rate Elastomeric Pumps
o Variable Rate Elastomeric Pumps

By Application
o Pain Management
o Antibiotic/Antiviral
o Chemotherapy
o Chelation Therapy
o Others

By End User
o Hospitals
o Clinics
o Homecare
o Ambulatory Surgical Centers (ASC)

Geography
o North America
U.S
Canada

o Europe
Germany
France
U.K
Italy
Spain
Russia
Poland
Rest of Europe

o Asia-Pacific
Japan
China
India
Australia & New Zealand
ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
South Korea
Rest of Asia-Pacific

Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-PBI-HnM-3156/

o Latin America
Brazil
Mexico
Argentina
Venezuela
Rest of Latin America

o Middle East and Africa (MEA)
Gulf Cooperation Council (GCC) Countries
Israel
South Africa

Rest of MEA

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) The Hair Loss and Growth Treatments and Products Market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Hair Loss & Growth Treatments and Products industrial chain, this report mainly elaborate the definition, types, applications and major players of Hair Loss & Growth Treatments and Products market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Hair Loss & Growth Treatments and Products market.

The Hair Loss & Growth Treatments and Products market can be split based on product types, major applications, and important regions.

Get Free Sample Report@ www.qurateresearch.com/report/sample/RCG/QBI-MR-RCG-768

Major Players in Hair Loss & Growth Treatments and Products market are:
Lifes2Good
Zhang Guang
Yanagiya
Avalon Natural Products
Nanogen
Taisho
Kaminomoto
Unilever
Gerolymatos International
Pharma Medico
Johnson & Johnson Consumer Inc.
Shiseido
Bawang
DS Healthcare Group
Bayer
Ultrax Labs
Rohto
EcoHerbs Global
Phyto
Softto
Merck
Keranique
Oxford BioLabs Ltd.
Kerafiber
Toppik
L'Oreal
Procter & Gamble
Henkel

Major Regions play vital role in Hair Loss & Growth Treatments and Products market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Hair Loss & Growth Treatments and Products products covered in this report are:
Medicine Product
Shampoos and Conditioners

Most widely used downstream fields of Hair Loss & Growth Treatments and Products market covered in this report are:
Men
Women

Enquiry about Report@ www.qurateresearch.com/report/enquiry/RCG/QBI-MR-RCG-768

There are 13 Chapters to thoroughly display the Hair Loss & Growth Treatments and Products market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Hair Loss & Growth Treatments and Products Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Hair Loss & Growth Treatments and Products Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Hair Loss & Growth Treatments and Products.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Hair Loss & Growth Treatments and Products.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Hair Loss & Growth Treatments and Products by Regions (2013-2018).
Chapter 6: Hair Loss & Growth Treatments and Products Production, Consumption, Export and Import by Regions (2013-2018).
Chapter 7: Hair Loss & Growth Treatments and Products Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Hair Loss & Growth Treatments and Products.
Chapter 9: Hair Loss & Growth Treatments and Products Market Analysis and Forecast by Type and Application (2018-2023).
Chapter 10: Market Analysis and Forecast by Regions (2018-2023).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Get Customize Report@ www.qurateresearch.com/report/customize/RCG/QBI-MR-RCG-768

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) The Digital X-Ray Machine market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Digital X-Ray Machine industrial chain, this report mainly elaborate the definition, types, applications and major players of Digital X-Ray Machine market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Digital X-Ray Machine market.

The Digital X-Ray Machine market can be split based on product types, major applications, and important regions.

Get Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-MR-HnM-784

Major Players in Digital X-Ray Machine market are:
Hitachi
Esaote
GE Healthcare
Siemens Healthcare
Toshiba
Samsung Medison
Hologic
Shimadzu
Carestream
Philips Healthcare

Major Regions play vital role in Digital X-Ray Machine market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Digital X-Ray Machine products covered in this report are:
CR
DR

Most widely used downstream fields of Digital X-Ray Machine market covered in this report are:
Hospital
Clinic
Other

Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-MR-HnM-784

There are 13 Chapters to thoroughly display the Digital X-Ray Machine market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Digital X-Ray Machine Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Digital X-Ray Machine Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Digital X-Ray Machine.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Digital X-Ray Machine.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Digital X-Ray Machine by Regions (2013-2018).
Chapter 6: Digital X-Ray Machine Production, Consumption, Export and Import by Regions (2013-2018).
Chapter 7: Digital X-Ray Machine Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Digital X-Ray Machine.
Chapter 9: Digital X-Ray Machine Market Analysis and Forecast by Type and Application (2018-2023).
Chapter 10: Market Analysis and Forecast by Regions (2018-2023).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Enquiry for Customization@ www.qurateresearch.com/report/customize/HnM/QBI-MR-HnM-784

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) The Breast Pump market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Breast Pump industrial chain, this report mainly elaborate the definition, types, applications and major players of Breast Pump market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Breast Pump market.

The Breast Pump market can be split based on product types, major applications, and important regions.

Get Free Sample Report@ www.qurateresearch.com/report/sample/RCG/QBI-MR-RCG-795

Major Players in Breast Pump market are:
Bailey Medical Engineering
Albert Manufacturing USA.
Hygeia Health
Whittlestone, Inc.
Linco Baby Merchandise Works Co. Ltd.
Energizer Holdings Inc.
Medela AG
Koninklijke Philips N.V.
Ameda, Inc.
Pigeon Corporation

Major Regions play vital role in Breast Pump market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Breast Pump products covered in this report are:
Battery Powered Breast Pumps
Manual Breast Pumps
Electric Breast Pumps

Most widely used downstream fields of Breast Pump market covered in this report are:
Personal
Hospital

Enquiry about Report@ www.qurateresearch.com/report/enquiry/RCG/QBI-MR-RCG-795

There are 13 Chapters to thoroughly display the Breast Pump market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Breast Pump Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Breast Pump Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Breast Pump.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Breast Pump.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Breast Pump by Regions (2013-2018).
Chapter 6: Breast Pump Production, Consumption, Export and Import by Regions (2013-2018).
Chapter 7: Breast Pump Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Breast Pump.
Chapter 9: Breast Pump Market Analysis and Forecast by Type and Application (2018-2023).
Chapter 10: Market Analysis and Forecast by Regions (2018-2023).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Enquiry for Customization@ www.qurateresearch.com/report/customize/RCG/QBI-MR-RCG-795

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) The Point Of Care Testing(Poct) market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Point Of Care Testing(Poct) industrial chain, this report mainly elaborate the definition, types, applications and major players of Point Of Care Testing(Poct) market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Point Of Care Testing(Poct) market.

The Point Of Care Testing(Poct) market can be split based on product types, major applications, and important regions.

Get Free Sample Report@ www.qurateresearch.com/report/sample/CnM/QBI-MR-CnM-833

Major Players in Point Of Care Testing(Poct) market are:
Alere
BD
Affymetrix
Bayer
Abbott
Johnson & Johnson
Agilent
Life Technology
Roche-diagnostics

Major Regions play vital role in Point Of Care Testing(Poct) market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Point Of Care Testing(Poct) products covered in this report are:
Microfluidic Technology
Minimally Invasive Technique
Others

Most widely used downstream fields of Point Of Care Testing(Poct) market covered in this report are:
In the hospital
Outside the hospital

Enquiry about Report@ www.qurateresearch.com/report/enquiry/CnM/QBI-MR-CnM-833

There are 13 Chapters to thoroughly display the Point Of Care Testing(Poct) market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Point Of Care Testing(Poct) Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Point Of Care Testing(Poct) Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Point Of Care Testing(Poct).

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Point Of Care Testing(Poct).

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Point Of Care Testing(Poct) by Regions (2013-2018).

Chapter 6: Point Of Care Testing(Poct) Production, Consumption, Export and Import by Regions (2013-2018).

Chapter 7: Point Of Care Testing(Poct) Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Point Of Care Testing(Poct).

Chapter 9: Point Of Care Testing(Poct) Market Analysis and Forecast by Type and Application (2018-2023).

Chapter 10: Market Analysis and Forecast by Regions (2018-2023).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Buy This Report@ www.qurateresearch.com/report/buy/CnM/QBI-MR-CnM-833/

Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) E-clinical Trial Solutions are a combination of technology, products and services that work together to automate and manage clinical trials. This term is used to refer to electronic systems that are used for conducting or automating the management of clinical trials and minimizing human errors. Conducting clinical trials for a novel drug requires efficient management of large amount of essential data with real-time analysis. Such management solutions improve efficiency, enhance the speed of clinical trials process, reduce clinical trial costs, and enable better data management and integration of different trial data for efficient observation.

The Global E-Clinical Trial Solutions market report is a comprehensive overview of the market covering various aspects such as product definition, various parameter-based segmentation, distribution channels, supply chain analysis, and common vendor environments. Through proven research methods, we collect thorough information that identifies the source. E-Clinical Trial Solutions Information about the market can be accessed in a logical format in a smart format. There are graphs and tables in place to help readers get a better view of the global E-Clinical Trial Solutions market.

Get Sample Copy Of this Report @ https://www.researchnreports.com/request_sample.php?id=221884

Companies Profiled in this Report includes: Oracle Corporation, Parexel International Corporation, Medidata Solution, Inc., BioClinica, DataTrak International, Inc., CRF Health, and others.

The E-Clinical solutions market is estimated to witness phenomenal growth over the forecast period. Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the growth of the market over the forecast period.

The growth of the global E-Clinical solutions market is driven by factors such as rising adoption of software solutions during clinical trials, increasing R&D expenditure by pharmaceutical companies, growing government grants to support clinical research, and rising customer base. In addition, increasing clinical research in emerging Asian countries, shift of clinical trials and resources from AMCs to CROs, and developments of cost effective modules are offering new growth opportunities for the E-Clinical solutions vendors. Nonetheless, the high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are the key reasons hampering the growth of the E-Clinical solutions market.

Get Reasonable Discount on This Premium Report @ https://www.researchnreports.com/ask_for_discount.php?id=221884

Based on geographical areas, the world E-Clinical Trial Solutions markets are broadly divided into Latin America, Europe, the Middle East and Africa and Asia Pacific. The world market is still in exploration in most areas, but it has the promising potential to grow steadily over the next few years. The major players investing in this market are in Canada, the United Kingdom, the United States, India, China and some Asia Pacific countries. As a result, Asia Pacific, North America and Western Europe are expected to account for more than half of the total market share over the next few years.

At the end of the report, a manufacturer is announced who is responsible for increasing sales in the E-Clinical Trial Solutions market. These manufacturers have been analyzed in terms of manufacturing base, basic information and competitors. In addition, the technology and product types introduced by each manufacturer are also an important part of this section of the report.

To Get More Information @ https://www.researchnreports.com/enquiry_before_buying.php?id=221884

Table of Content:

Global E-Clinical Trial Solutions Market Research Report

Chapter 1 E-Clinical Trial Solutions Market Overview
Chapter 2 Global Economic Impact
Chapter 3 Competition by Manufacturer
Chapter 4 Production, Revenue (Value) by Region
Chapter 5 Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Production, Revenue (Value), Price Trend by Type
Chapter 7 Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Market Forecast
Chapter 13 Appendix

Mr. Sunny Denis
+1 888-631-6977
sales@researchnreports.com

Source: EmailWire.Com

Coherent Market Insights

(EMAILWIRE.COM, July 30, 2018 ) Global Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) has potential pipeline products and is estimated to reach US$ 140.4 Mn by 2023, as highlighted in a new report published by Coherent Market Insights.

Pharmaceutical companies are focusing on enhancing research and development for introducing novel therapeutics to address unmet patient needs. For instance, the discovery and development of siRNA (small interfering RNA) therapeutics by Sirnaomics, Inc., with dual-target properties and polypeptide nanoparticle (PNP)-enhanced delivery that directly controls the fibrotic and inflammatory activity is expected to have wide applications in many inflammatory and fibrotic diseases.

The support from public and private organizations such as PSC Support Organization and National Organization for Rare Disorders serves as the hub of rare disease community, providing assistance programs for patients and advancing clinical trials by granting funds for advanced research programs. The UK PSC Support Organization granted US$ 20,000 to the University of Birmingham for supporting the research and investigation of Vascular Adhesion Protein (VAP-1) in primary sclerosing cholangitis (PSC). Also, in 2017, the Falk Foundation funded a European multi-center phase II study led by the Medical University of Vienna in collaboration with the Medical University of Graz and the Medical University of Hannover, to treat primary sclerosing cholangitis.

Browse through 134 Pages and an in-depth TOC on Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).

Latest trends and insights prevalent in the primary sclerosing cholangitis market

Orphan drug designation granted by regulatory agencies such as the Food and Drug Administration (FDA) and European Medicine Agency (EMA) for the treatment of PSC enables manufacturers to accelerate drug development process for providing new drug treatments to patients in need. For instance, in 2017, Conatus Pharmaceuticals Inc. was granted orphan designation to IDN-7314 by the FDA and EMA. The drug completed two successful pre-clinical trials, of which the second one was completed in 2017. Also, in 2016, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for BTT1023 drug candidate developed by Acorda Therapeutics, which is in Phase 2 clinical trials currently.

Also, pharmaceuticals companies are focusing on mergers and acquisitions to accelerate the development of new treatment options to address the unmet needs of patients suffering from rare diseases by advancing the therapies into clinical trials. For instance, in 2015, Gilead Sciences, Inc. acquired Phenex Pharmaceuticals AG, to gain access to Phenexs Farnesoid X Receptor (FXR) program comprising small molecule FXR agonists for the treatment of liver diseases including PSC and nonalcoholic steatohepatitis (NASH). Also, in February, 2018, Intercept Pharmaceuticals, Inc. collaborated with Sumitomo Dainippon Pharma Co. Ltd., to develop and commercialize Obeticholic Acid (OCA) for chronic liver disease in Japan, China, and Korea.

In 2014, Shire acquired Lumena Pharmaceuticals, to gain access to its late stage rare disease pipeline assets indicated for gastrointestinal conditions- LUM001 and LUM002, thus providing potential treatment options to patients with rare cholestatic liver disease and adding products to its rare disease portfolio.

Click here to buy this Market Intelligence Report

Click the Link below to have a look at a Sample before buying

Request Sample

Key Takeaways of the Primary Sclerosing Cholangitis Market:

According to the Research Institute of Radiological Science, 2016, the prevalence of PSC is higher in Northern Europe and the U.S. around 10 per 100,000 population, while it is far less common in Southern Europe and Asia
Requirement of providing affordable treatment, owing to high costs associated with liver transplantation coupled with increasing risk factors resulting in the development of serious disorders are factors that are expected to bolster market growth in the near future.
Some of the major players operating in the global primary sclerosing cholangitis market include Acorda Therapeutics, Inc., Gilead Sciences, Inc., NGM Biopharmaceuticals, Inc., Intercept Pharmaceuticals, Inc., Dr. Falk Pharma GmbH, Allergan Plc., Shire Plc., Durect Corporation, Conatus Pharmaceuticals, Inc., Sirnaomics, Inc., and Shenzhen HighTide Biopharmaceutical Ltd.
About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Mr. Shah
2067016702
sales@coherentmarketinsights.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) The report contains 103 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Heart Rate Monitor Watch market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Non-Heart Rate Monitor Watch global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2018 - 2023.

Get FREE Exclusive PDF Sample Copy of This Report

The scope of the report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions. The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on. The statistics are represented in graphical format for a clear understanding on facts and figures.

The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders. Secondary research techniques are implemented for better understanding and clarity for data analysis.

The report for Heart Rate Monitor Watch market industry analysis & forecast 2018-2023 is segmented into Product Segment, Application Segment & Major players.

Region-wise Analysis Global Heart Rate Monitor Watch Market covers:
North America
Europe
China
Japan
Southeast Asia
India

The Report covers in-depth analysis as follows:
Chapter 1 Heart Rate Monitor Watch Market Overview
Chapter 2 Global Economic Impact on Heart Rate Monitor Watch Industry
Chapter 3 Global Heart Rate Monitor Watch Market Competition by Manufacturers
Chapter 4 Global Heart Rate Monitor Watch Production, Revenue (Value) by Region (2013-2018)
Chapter 5 Global Heart Rate Monitor Watch Supply (Production), Consumption, Export, Import by Regions (2013-2018)
Chapter 6 Global Heart Rate Monitor Watch Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Heart Rate Monitor Watch Market Analysis by Application
Chapter 8 Global Heart Rate Monitor Watch Manufacturers Analysis
Chapter 9 Heart Rate Monitor Watch Manufacturing Cost Analysis
Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 11 Marketing Strategy Analysis, Distributors/Traders
Chapter 12 Market Effect Factors Analysis
Chapter 13 Global Heart Rate Monitor Watch Market Forecast (2018-2023)

Gain Full Access of Heart Rate Monitor Watch market industry analysis & forecast 2018-2023 along with complete

Global Heart Rate Monitor Watch Market Industry Analysis and Forecast 2018-2023 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market-driven results deriving feasibility studies for client needs. UpMarketResearch ensures qualified and verifiable aspects of market data operating in the real-time scenario. The analytical studies are conducted ensuring client needs with a thorough understanding of market capacities in the real-time scenario.

Key Reasons to Purchase:
To gain insightful analyses of the market and have a comprehensive understanding of the Global Heart Rate Monitor Watch Market Industry Analysis and Forecast 2018-2023 and its commercial landscape
Learn about the market strategies that are being adopted by your competitors and leading organizations
To understand the future outlook and prospects for Heart Rate Monitor Watch market industry analysis and forecast 2018-2023.

Customization of the Report:
UpMarketResearch provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Browse more reports by Up Market Research:
Global Snow Melting System Market Industry Analysis & Forecast 2018-2023

Global Battery Energy Storage Systems for Smart Grid Market Industry Analysis & Forecast 2018-2023

About UpMarketResearch:
UpMarketResearch (www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Contact Info:
Name: Alex Mathews
Email: Alex@upmarketresearch.com
Organization: UpMarketResearch
Address: 500 East E Street, Ontario, CA 91764, United States

Alex Mathews
+1 (347) 349-6713
alex@upmarketresearch.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 30, 2018 ) According to a new market research report "Sinus Dilation Devices Market by Product (Balloon Dilation, Stents, Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric), Patient Care Setting (ENT, Clinic, Hospitals, ASC) - Global Forecast to 2023", published by MarketsandMarkets, the global market is expected to reach USD 2.78 Billion by 2023 from USD 1.80 Billion in 2018, at a CAGR of 9.1%.

The growth of the market can be attributed to the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries.

Balloon sinus dilation devices segment is expected to dominate the market in 2018

Based on product, the Sinus Dilation Devices Market is segmented into balloon sinus dilation devices, endoscopes, sinus stents/implants, and handheld instruments. The balloon Sinus Dilation Devices Market is further classified as standalone and hybrid according to the type of procedure. In 2018, balloon sinus dilation devices are expected to account for the largest share of the global Sinus Dilation Devices Market. This large share can be attributed to the rising prevalence of chronic sinusitis, increasing preference for minimally invasive surgical procedures, and the increasing focus of market players on launching advanced balloon sinus dilation devices.

Based on patient care setting, the ENT clinics/in office segment is projected to grow at the highest CAGR during the forecast period

Based on patient care setting, the Sinus Dilation Devices Market is segmented into hospitals, ambulatory surgical centers, and ENT clinics/in office. The ENT clinics/in office segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to increasing number of treatable patients in ENT clinics, faster recovery time, cost-effectiveness, and growing preference for minimally invasive techniques.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=64349810

North America is expected to dominate the Sinus Dilation Devices Market in 2018

In 2018, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to rapidly increasing geriatric population, rising prevalence of chronic sinusitis, higher adoption of new technologies among ENT surgeons and otolaryngologists, favorable reimbursement scenario, and the presence of major players in this region.

The Sinus Dilation Devices Market includes various small and large players. Key players in this market include Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland).

Know more about the Sinus Dilation Devices Market:
rnhttps://www.marketsandmarkets.com/Market-Reports/sinus-dilation-device-market-64349810.html

Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com

Source: EmailWire.Com

Coherent Market Insights

(EMAILWIRE.COM, July 30, 2018 ) The Global Electroceutical Devices Market, by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Retinal Implants, Cochlear Implants, Spinal cord Stimulators, Deep brain Stimulators, and Others), by Modality (Implantable Electroceutical Devices and Non-Invasive Electroceutical Devices), by Application (Pain Management, Wound Healing, Atrial Fibrillation, Coronary Artery Disease, Diabetes, Arthritis, Hypertension, Gastrointestinal Diseases, and Others Applications), By End User (Hospitals, Academic Research Institutions, and Ambulatory Surgical Centers), was valued US$ 17.8 billion in 2018, and is projected to exhibit a CAGR of 8.0% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.

Electroceuticals are medical devices, which employ electrical currents to affect and modify body functions as an alternative to drug-based interventions. In contrast to pacemakers and other classical excitable-tissue stimulators, modern electroceutical devices employ sophisticated control strategies in order to modulate physiological regulation. For instance, modulation of cardiac contractility as a therapy for heart failure, modulation of gastric contractility as a therapy for diabetes, and modulation of vagus nerve traffic as a therapy for epilepsy and inflammatory diseases.

Market players are actively investing in research and development to develop more efficient and innovative electroceutical devices and also retaining organic and in-organic strategies, which thereby offer lucrative opportunities in this market.

For instance, in November 2017, LivaNova PLC and MicroPort Scientific Corporation entered into a binding Letter of Intent (LOI) to sale LivaNovas Cardiac Rhythm Management (CRM) business franchise to MicroPort for US$ 190 million. Companys CRM product portfolio includes pacemakers, high-voltage defibrillators, and cardiac resynchronization therapy devices. The acquisition helps MicroPort to add these diverse cardiac rhythm management portfolio to their existing product portfolio.

In August 2014, Medtronic plc completed acquisition of Sapiens Steering Brain Stimulation (Sapiens SBS): a developer of Deep Brain Stimulation (DBS) technologies; for deal value of US$ 200 million. Moreover, acquisition of Sapiens SBS strengthens Medtronic's capabilities in modulation of brain function.

Browse 32 Market Data Tables and 36 Figures spread through 192 Pages and in-depth TOC on "Electroceutical Devices Market, by Product (Cardiac Pacemakers, Implantable Cardioverter Defibrillators, Retinal Implants, Cochlear Implants, Spinal cord Stimulators, Deep brain Stimulators and Others), by Modality (Implantable Electroceutical Devices and Non-Invasive Electroceutical Devices), by Application (Pain Management, Wound Healing, Atrial Fibrillation, Coronary Artery Disease, Diabetes, Arthritis, Hypertension, Gastrointestinal Diseases, and Other Applications), By End User (Hospitals, Academic Research Institutions, and Ambulatory Surgical Centers) - Global Forecast to 2026"

Latest trends and insights prevalent in the electroceutical devices market

Furthermore, key players are engaged in launching innovative electroceutical devices portfolio in market along with gaining regulatory approval for the same.

For instance, in November 2017, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for their portfolio of Azure pacemakers with BlueSync technology, which is available in both single and dual chamber cardiac pacemakers. Companys new Azure XT MRI and Azure S MRI pacemakers offer improved longevity, which is an estimated at 13.7 years (dual chamber).

Moreover, in November 2017, Cochlear Limited; received the U.S.FDA approval for first remote feature to nucleus cochlear implant system thorough a telemedicine platform, which allow follow-up programming sessions. This approval is first in the artificial cochlear implant industry, benefiting various cochlear implant patients who are unable to access consistent follow-ups.

Furthermore, manufacturers of implantable cardiac pacemakers are updating their product portfolio by implementing inorganic growth strategies to sustain their foothold in the market. In April 2016, Medtronic plc received U.S.FDA approval for the world's smallest pacemaker, the Medtronic Micra Transcatheter Pacing System (TPS). The Micra TPS is based on miniaturized pacing technology, which allows it to be delivered through a catheter and implanted directly into the heart.

Click here to buy this Market Intelligence Report

Click the Link below to have a look at a Sample before buying

Request Sample

Key takeaways of the Electroceutical Devices Market:

The global electroceutical devices market is expected to expand at a CAGR of 8.0% during the forecast period (2018 2026), owing to growing engagement of various market players to develop innovative electroceutical devices
Among product segment, implantable cardioverter defibrillators segment accounted for high revenue share in market, owing to its wide application in various heart disease conditions. According to American Heart Association (AHA), implantable cardioverter defibrillator play major role in preventing cardiac arrest in high-risk patients of ventricular arrhythmias.
Implantable electroceutical devices hold major market share in modality segment. Implantable electroceutical devices are being used for long period, along with that these devices offer continuous treatment within the patients body and provides easy environment for easy treatment of patients.
On the basis of application segment, electroceutical devices market is segmented into product such as cardiac pacemakers and implantable cardioverter defibrillators (used for Atrial Fibrillation, Coronary Artery Disease), cochlear implants (used for sensorineural hearing loss), retinal implants (used for retinal pigmentosa), spinal cord stimulators (used for chronic pain, failed back surgery, and ischemia), deep brain stimulators (used for Parkinson's disease, tremors, depression, and others), and other electric stimulators (used for gastro paresis, obesity, depression, migraine headaches, and spinal cord injuries).
Hospitals hold major market share in end user segment, owing to increased number of electroceutical devices implant procedures in hospitals.
Some of the major players operating in global electroceutical devices market include Medtronic plc, Abbott Laboratories, Cochlear Ltd. Sonova Holding AG, Advanced Bionics AG, Boston Scientific Corporation, electroCore, Inc., Biotronik, ReShape Lifesciences, Inc., and LivaNova, PLC.
About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Mr. Shah
2067016702
sales@coherentmarketinsights.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) https://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html

The global computer-assisted coding market is projected to reach USD 4.75 Billion by 2022 at a CAGR of 11.5% during the forecast period. The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the rising demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures. However, high implementation and maintenance expenses for computer-assisted coding and lack of IT professionals in the healthcare industry are likely to hinder the growth of the market to some extent.

The computer-assisted coding market in this report is segmented on the basis of by product and service, application, mode of delivery, and end user. This report also provides market information on major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World.

In 2016, the solutions segment dominated the product and service computer-assisted coding market. The solutions segment is subsegmented into standalone software and integrated software. The integrated computer-assisted coding software segment is the fastest-growing segment of the global computer-assisted coding solutions. This can be attributed to the growing need for optimized computer-assisted coding software for seamless workflow and successful data integration within healthcare provider systems.

Based on application, the market is categorized into three types automated computer-assisted encoding, management reporting and analytics, and clinical code auditing. The automated computer-assisted encoding segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to usage benefits such as the improvement in the quality of clinical-coded diagnosis and procedures encoding productivity of coders while ensuring better revenue capture through coding, decreased coding variability, and efficient problem documentation for quick review and maximization of the return on investment.

By mode of delivery, the global computer-assisted coding market is segmented into web-based solutions, cloud-based solutions, and on-premise solutions. In 2016, the web-based solutions segment dominated the global market. This growth can be attributed to the advantage of its flexible, scalable, and affordable nature and additional advantage of a separate cloud for the client along with a public cloud server and easy access to information for users operating in different time zones and geographic locations.

The major end users of computer-assisted coding are healthcare providers and healthcare payers. The providers are further segmented into hospitals, physicians practices, clinical laboratories, academic medical centers, and other healthcare institutions. In 2016, the providers dominated the global computer-assisted coding market. This is primarily attributed to the significant demand for CAC solutions among hospitals and physicians/clinics for improving data accuracy and productivity maximize hospital revenue by minimizing coding errors, and shortening the claims reimbursement cycle.

Geographically, the global computer-assisted coding market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the global market. The rising need to minimizing operational errors, thereby reducing healthcare costs, increasing government efforts toward strengthening the healthcare infrastructure through the implementation of healthcare IT solutions and improving the quality of care are driving the growth of the market in this region. Asia-Pacific is the fastest-growing market for computer-assisted coding. The growth of the global market across the Asia-Pacific region is primarily driven by the escalating demand to reduce the burden of the healthcare systems, curtail healthcare delivery costs, increasing implementation of healthcare IT solutions, and the various government initiatives for enabling efficient, affordable, and on-time delivery of quality care.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=170644018

In 2016, 3M Company (U.S.) and Optum, Inc. (U.S.) dominated the global computer-assisted coding market. Some of the prominent players in the market are Nuance Communications, Inc. (U.S.), Cerner Corporation (U.S.) and Artificial Medical Intelligence, Inc. (U.S.). Some of the other leading players in this market are Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Streamline Health Solutions, Inc. (U.S.), MMODAL IP LLC (M*Modal) (U.S.), TruCode (U.S.), Quest Diagnostics Inc. (U.S.), and Epic Systems Corporation(U.S.).

Request for Customization:
rnhttps://www.marketsandmarkets.com/requestCustomization.asp?id=170644018

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
UK : +44-800-368-9399
sales@marketsandmarkets.com

Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) The global glycomics market is poised to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth.
rnhttps://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html
On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of end user, the glycomics market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and CROs. In 2016, the academic research institutes segment is projected to account for the largest share of the market. This growth can be attributed to the increasing government and private funding for proteomic and glycomics research.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

In 2015, the global glycomics market was dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Over the next five years, the growth of the glycobiology market in the Asian region is likely to be centered on China, India, and Japan.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=132685525

The key players in the glycomics market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Request for Customization: https://www.marketsandmarkets.com/requestCustomization.asp?id=132685525

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
UK : +44-800-368-9399
sales@marketsandmarkets.com

Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) The varicose vein treatment market in North America and Europe is projected to reach to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, growing at a CAGR of 6.9% from 2016 to 2021.
rnhttps://www.marketsandmarkets.com/Market-Reports/varicose-vein-treatment-market-22524107.html

Objectives of the study are:

To define, describe, and forecast the varicose vein treatment market in North America and Europe on the basis of mode of treatment, products, and regions
To provide detailed information regarding major factors influencing the growth of the varicose vein treatment market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile the key players and comprehensively analyze their market shares
To estimate and forecast the varicose vein treatment market by mode and product in North America (U.S. and Canada) and Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)
Research Methodology

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=22524107

As of 2015, Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), and biolitec AG (Austria) are some of the key players of the varicose vein treatment market in North America and Europe. Major market players were witnessed to adopt organic as well as (new product launches) as well as inorganic growth strategies (acquisitions and agreements) to enhance their market shares and positions during 2013-2016; with new product launch being the most-prominent growth strategy adopted by majority of market players. Several market players also pursued the strategy of strategic acquisitions to strengthen their market positions and enhance their R&D capabilities.

The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the Varicose Vein Treatment market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of Varicose Vein Treatment market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the Varicose Vein Treatment market.

This report broadly segments the Varicose Vein Treatment market into mode of treatment and products. On the basis of mode of treatment, the Varicose Vein Treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the Varicose Vein Treatment market, by mode of treatment, in 2016.

Based on type of products, the Varicose Vein Treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

This report covers the Varicose Vein Treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=22524107

Major players in the varicose vein treatment market include Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

Request for Customization: https://www.marketsandmarkets.com/requestCustomization.asp?id=22524107

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
UK : +44-800-368-9399
sales@marketsandmarkets.com

Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com

Source: EmailWire.Com

(EMAILWIRE.COM, July 28, 2018 ) The medical robot market is anticipated to grow at a CAGR of 23.1% and reach US$ 26.67 Bn by 2025.

In the recent years, medical robot are being used extensively in healthcare owing to high precision and capacity of work without fatigue. These robot have their applications in several medical practices, such as, challenging surgical procedures, and have transformed the speed and efficacy of health care services.

Advantages offered by robot-assisted training in rehabilitation treatment and funding from government for medical robot research are the major drivers which are likely to aid the growth of medical robot market. Innovation in nanorobot technology for cancer treatment is expected to add new opportunities for this market in the coming years.

Get Sample PDF Illustration @ http://bit.ly/2KvuzxS

The Global Medical Robot Market Analysis to 2025 is a specialized and in-depth study of the medical robot industry with a focus on the global market trend. The report aims to provide an overview of global medical robot market with detailed market segmentation by product, application, end user, and geography. The global medical robot market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The medical robot market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global medical robot market based on product, application, and end user. It also provides market size and forecast till 2025 for overall medical robot market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

The medical robot market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Buying this Customized Report at @ http://bit.ly/2venbfw

The medical robot market report also includes the profiles of key medical robot manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Intuitive Surgical, Inc., Stryker Corporation, Hocoma AG, Mazor Robotics Ltd., Hansen Medical, Inc. (Auris Surgical Robotics), Accuray Incorporated., Omnicell, Inc., Arxium, EKSO Bionics Holdings, Inc., Kirby Lester, LLC, and among others.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com

Source: EmailWire.Com

Latest Images